Amphastar Pharmaceuticals, Inc. (AMPH)
27.74
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
27.72
-0.02
(-0.05%)
After-Hours: 20:00
Amphastar Pharmaceuticals Research and Development Expense (Annual): 61.43M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Supernus Pharmaceuticals, Inc. | 106.36M |
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Pfizer Inc. | 10.74B |
| CorMedix, Inc. | 3.942M |